Stay updated on Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial
Sign up to get notified when there's something new on the Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial page.

Latest updates to the Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedUpdated the Locations section to include additional sites across the U.S. and Canada (Alabama, Arizona, California, Florida, Illinois, Kansas, Kentucky, Louisiana, Maryland, Minnesota, Missouri, Montana, New Jersey, Ohio, Pennsylvania, Rhode Island, Tennessee, Texas, Washington, Alberta, Ontario). The page also shows removal of certain location entries and an updated revision note.SummaryDifference1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed, which are minor site maintenance updates and do not affect study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedThe Taiwan locations were updated: 'Tainan City, Taiwan' was removed and a new 'Tainan, Taiwan' site added to the study locations.SummaryDifference0.2%

- Check63 days agoChange DetectedNo significant changes to core content were detected; the PHOCUS study page remains consistent.SummaryDifference0.2%

- Check91 days agoChange DetectedSummary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check99 days agoChange DetectedThe page updates its version tag from v3.0.2 to v3.1.0, signaling a version upgrade.SummaryDifference0.1%

Stay in the know with updates to Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial page.